Immune Biosolutions Inc.

Immune Biosolutions is an innovative biotech company focused on the discovery and engineering of chicken antibodies targeting difficult proteins with a validated, yet unexploited, therapeutic potential. We believe that chicken antibodies are an unexploited source of new therapeutics that could save 1 million lives before 2025. To capture the full potential of chicken antibodies, we have designed a multidisciplinary approach that combines bioinformatics, chemistry, physics, as well as biology, to create the best therapeutic entities. Our platform welcomes outside projects to create new synergies and amplify our impact on human health.